Datarithm adds InStockRx to liquidation engine for independent pharmacies

Datarithm said Aug. 27, 2026, that it is expanding its Liquidation Engine with InStockRx, giving independent pharmacies a second recovery path for dead stock beyond Rx Direct Solutions. The update is meant to help pharmacies turn slow-moving inventory into cash faster as reimbursement pressure and operating costs squeeze margins.

Why it matters: - Independent pharmacies are under pressure from low reimbursements and rising operating costs. - Dead stock ties up working capital that could otherwise support operations, debt reduction or growth. - The expanded liquidation workflow gives pharmacies more than one way to recover value from inventory that has stopped moving.

What happened: - Datarithm announced an expansion of its Liquidation Engine through a new partnership with InStockRx. - The new integration adds to Datarithm’s existing partnership with Rx Direct Solutions. - The combined setup gives independent pharmacies two recovery paths for dead stock: manufacturer return and direct marketplace resale. - The announcement was made Aug. 27, 2026, from Syracuse, New York.

The details: - Datarithm defines dead stock as inventory that has not moved in four-plus months and no longer qualifies for wholesaler return or store-to-store transfer. - Rx Direct Solutions handles manufacturer return. - Rx Direct Solutions verifies return policy, provides a real-time NADAC-based credit estimate and generates paperwork needed to ship inventory back. - InStockRx handles direct resale through a DSCSA-compliant marketplace. - The marketplace is designed for items not yet eligible for manufacturer return or not suited for that route. - Pharmacies can list surplus inventory for other independent pharmacies to buy. - The marketplace pricing is often below wholesaler cost. - Datarithm said the Liquidation Engine now covers the full range of dead-stock outcomes from a single screen. - Datarithm’s software continually scans pharmacy management systems to identify slow-moving NDCs before they reach expiration thresholds. - The InStockRx integration also lets pharmacies buy surplus inventory listed by other pharmacies. - Recaptured capital can be redeployed into business expansion or debt reduction. - Datarithm pointed pharmacies to more information, Rx Direct Solutions and InStockRx.

Between the lines: - The partnership extends Datarithm from inventory detection into inventory recovery and resale. - The setup is designed to reduce the lag between identifying dead stock and turning it into cash. - Jeremy Froehner, founder of InStockRx, said independent pharmacies have had inventory data but lacked a simple way to act on it. - Dave Belinski, president of Datarithm, said the combined paths leave no dead-stock category that customers are stuck holding.

What's next: - Independent pharmacies can use the expanded workflow to move inventory through either return or resale, depending on eligibility. - Datarithm, Rx Direct Solutions and InStockRx are positioning the integration as a way to speed working-capital recovery for pharmacy owners. - Pharmacies interested in optimizing inventory workflows can contact the companies through their websites.

The bottom line: - Datarithm is broadening its liquidation tools so independent pharmacies have a clearer path from stagnant inventory to cash.